Neurostimulation: Technologies and Global Markets

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,500	160 Pages	BCC Research	September, 2023	WA18180610

Best Price Guarantee
Price	from $5,500
Length	160 Pages
Publisher	BCC Research
Published Date	September, 2023
SKU	WA18180610

Neurostimulation: Technologies and Global Markets

Report Scope:

This report provides a comprehensive study of the global market for neurostimulation technologies and devices. It provides a detailed description of the different types of neurostimulation technologies and devices (invasive and noninvasive) and their current and historical market revenues.

Neurostimulation technologies and devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.

This report also covers in detail the therapeutic applications of neurostimulation technologies and devices, including chronic pain, Parkinson’s disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies and devices includes historical data and market projections by device type, therapeutic application and region.

Report Includes:

51 tables

An overview of the global markets and technologies for neurostimulation

Estimation of the market size and analyses of market trends, with data from 2020 to 2022, estimates for 2023 and projection of CAGR through 2028

Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases

Detailed description of various types of stimulation such as spinal cord stimulation, transcutaneous electrical nerve stimulation, deep brain stimulation, sacral nerve stimulation, Vagus nerve stimulation, hypoglossal nerve stimulation, and transcranial magnetic stimulation; and discussion on their mode of action and advantages

Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies

Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies

Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth

Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies

Comprehensive company profiles of major players of the industry, including Axonics Inc., Boston Scientific Corp., Medtronic PLC, Synapse Biomedical Inc. and Xavant Technology

Companies Mentioned

ABBOTT LABORATORIES
ALEVA NEUROTHERAPEUTICS SA
AVERY BIOMEDICAL DEVICES INC.
AXONICS INC.
BIOINDUCTION LTD.
Bioventus LLC
BIOWAVE CORP.
BOSTON SCIENTIFIC CORP.
BRAINSWAY LTD.
COCHLEAR AMERICAS
CVRX INC.
ELECTROCORE INC.
INSPIRE MEDICAL SYSTEMS INC.
INTEGER HOLDINGS CORP.
LABORIE INC.
LIVANOVA PLC
MAG & MORE GMBH
MAGSTIM INC.
MEDTRONIC PLC
NALU MEDICAL INC.
NEUROMED CONSULTING INC.
NEUROMETRIX INC.
NEURONETICS INC.
NEUROPACE INC.
NEUROSIGMA INC.
NEUROVALENS LTD.
NEVRO CORP.
NEXSTIM PLC
NYXOAH SA
SOTERIX MEDICAL INC.
SYNAPSE BIOMEDICAL INC.
XAVANT TECHNOLOGY (PTY) LTD.
ZOLL MEDICAL CORP.

Chapter 1 Introduction: Study Goals and Objectives; Reasons for Doing the Study; What's New in This Update?; Scope of Report; Methodology and Information Sources; Regional Breakdown
Chapter 2 Summary and Highlights: Market Outlook
Chapter 3 Market and Technology Background: Overview of Neurostimulation; Types of Neurostimulation Technologies; Spinal Cord Stimulation; Deep Brain Stimulation; Sacral Nerve Stimulation (SNS); Vagus Nerve Stimulation; Hypoglossal Nerve Stimulation; Transcutaneous Electrical Nerve Stimulation; Transcranial Magnetic Stimulation (TMS); Other Neurostimulation Technologies; Therapeutic Applications for Neurostimulation; Chronic Pain Management; Neurological Disorders; Urinary and Fecal Incontinence; Obstructive Sleep Apnea; Chronic Migraine and Headache; Cardiovascular Diseases; Gastrointestinal Disorders; Obesity; Psychiatric Disorders; Technological Developments; MRI Compatibility; Rechargeable and Non-rechargeable Devices
Chapter 4 Market Dynamics: Market Trends; Drivers; Market Restraints
Chapter 5 Market Breakdown by Technology/Device Type: Global Market for Neurostimulation Devices by Type; Spinal Cord Stimulation (SCS) Devices; Transcutaneous Electrical Nerve Stimulation (TENS) Devices; Deep Brain Stimulation (DBS) Devices; Sacral Nerve Stimulation (SNS) Devices; Vagus Nerve Stimulation (VNS) Devices; Hypoglossal Nerve Stimulation (HGNS) Devices; Market Size and Forecast; Transcranial Magnetic Stimulation (TMS) Devices; Other Types of Neurostimulation Devices
Chapter 6 Market Breakdown by Therapeutic Application: Global Market for Neurostimulation Devices by Therapeutic Application; Chronic Pain; Urinary and Fecal Incontinence; Parkinson's Disease; Epilepsy; Obstructive Sleep Apnea (OSA); Essential Tremor; Major Depressive Disorder (MDD)/Clinical Depression; Obsessive Compulsive Disorder (OCD); Other Therapeutic Applications
Chapter 7 Market Breakdown by Region: Global Market for Neurostimulation Devices by Region; North America; Europe; Asia-Pacific; Rest of the World
Chapter 8 Regulatory Structure: Regulatory Framework; U.S.; European Union; Japan
Chapter 9 Key Products and Technologies on the Market: Recent Therapeutic Improvements and New Indications; Spinal Cord Stimulation; Deep Brain Stimulation; Sacral Nerve Stimulation (SNS); Axonics; Medtronic; Vagus Nerve Stimulation; Hypoglossal Nerve Stimulation; Transcutaneous Electrical Nerve Stimulation; Transcranial Magnetic Stimulation; Other Types of Stimulation; New Indications and Neurostimulation Therapies
Chapter 10 Emerging Technologies and Developments: Emerging Technologies and Developments; Closed-Loop Neurostimulation; Non-Invasive Brain Stimulation Techniques; High-Frequency Stimulation; Magnetic Resonance-guided Focused Ultrasound; Optogenetics; Bioelectronic Medicine; Wireless and Remote-Controlled Devices
Chapter 11 Recent M&A: M&A in the Neurostimulation Technologies Industry
Chapter 12 Competitive Landscape: Company Market Shares by Product Segment; Spinal Cord Stimulation Devices; Deep Brain Stimulation Devices; Sacral Nerve Stimulation Devices; Vagus Nerve Stimulation Devices; Hypoglossal Nerve Stimulation Devices; Transcranial Magnetic Stimulation Devices; Transcutaneous Electrical Nerve Stimulation Devices; Recent Industry Activities
Chapter 13 Company Profiles: ABBOTT LABORATORIES; ALEVA NEUROTHERAPEUTICS SA; AVERY BIOMEDICAL DEVICES INC.; AXONICS INC.; BIOINDUCTION LTD.; BIOVENTUS LLC; BIOWAVE CORP.; BOSTON SCIENTIFIC CORP.; BRAINSWAY LTD.; COCHLEAR AMERICAS; CVRX INC.; ELECTROCORE INC.; INSPIRE MEDICAL SYSTEMS INC.; INTEGER HOLDINGS CORP.; LABORIE INC.; LIVANOVA PLC; MAG & MORE GMBH; MAGSTIM INC.; MEDTRONIC PLC; NALU MEDICAL INC.; NEUROMED CONSULTING INC.; NEUROMETRIX INC.; NEURONETICS INC.; NEUROPACE INC.; NEUROSIGMA INC.; NEUROVALENS LTD.; NEVRO CORP.; NEXSTIM PLC; NYXOAH SA; SOTERIX MEDICAL INC.; SYNAPSE BIOMEDICAL INC.; XAVANT TECHNOLOGY (PTY) LTD.; ZOLL MEDICAL CORP.
Chapter 14 Appendix: Acronyms